Pieris’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Pieris is a biotechnology company that discovers, develops and commercializes anticalin-based drugs for the treatment of respiratory diseases. Read more

Stephen S. Yoder's photo - President & CEO of Pieris

President & CEO

Stephen S. Yoder

CEO Approval Rating

84/100

Founded:

2001

Status:

PublicNASDAQPIRS

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

MacroGenics is Pieris's top competitor. MacroGenics is a Public company that was founded in Rockville, Maryland in 2000. MacroGenics operates in the Biotechnology industry. MacroGenics has 277 more employees vs. Pieris.

Molecular Partners has been one of Pieris's top competitors. Molecular Partners is headquartered in Schlieren, Zurich, and was founded in 2004. Molecular Partners is in the Biotechnology field. Molecular Partners generates 49% the revenue of Pieris.

F-star is perceived as one of Pieris's biggest rivals. F-star was founded in 2006 in Cambridge, England. F-star competes in the Biotechnology field. F-star generates $18.5M less revenue than Pieris.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Wacker a competitor of Pieris?

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$42.3M

Pieris's revenue is the ranked lowest among it's top 10 competitors. The top 10 competitors average 1.2B. Over the last four quarters, Pieris's revenue has decreased by 25.7%. Specifically, in Q2 2020's revenue was $11.2M; in Q1 2020, it was $13.3M; in Q4 2019, it was $17.3M; in Q3 2019, Pieris's revenue was $15.1M.

Acquisitions

No recent acquisitions found related to Pieris

Pieris Funding History

$16.5M$48.5M

Since Pieris was founded in 2001, it has participated in 2 rounds of funding. In total Pieris has raised $48.5M. Pieris' last funding round was on Nov 2019 for a total of $32.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Nov 2019
$32M
-
Equity
Jun 2016
$16.5M
-

Total Funding: $48.5M

Since Pieris was founded in 2001, it has participated in 2 rounds of funding. In total Pieris has raised $48.5M. Pieris' last funding round was on Nov 2019 for a total of $32.0M

Investments

No recent investments found related to Pieris

Pieris News

August 11, 2020PharmaTimes

Eli Lilly, Pieris collaborate on HER2-positive cancer clinical programme

Companies will focus on HER2-positive gastric cancer... See more »
August 10, 2020MarketScreener

Reports Second Quarter 2020 Financial Results and Provides Corporate Update

(marketscreener.com) Pieris Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provide... See more »
June 28, 2020Zolmax News

$7.73 Million in Sales Expected for Pieris Pharmaceuticals Inc (NASDAQ:PIRS) This Quarter

Wall Street brokerages predict that Pieris Pharmaceuticals Inc (NASDAQ:PIRS) will report sales of $7.... See more »
June 9, 2020marketexclusive

PIERIS PHARMACEUTICALS, INC. (NASDAQ:PIRS) Files An 8-K Other Events

PIERIS PHARMACEUTICALS, INC. (NASDAQ:PIRS) Files An 8-K Other Events Item 8.01. Other Events... See more »
June 8, 2020FinanzNachrichten

Pieris Pharmaceuticals Announces Virtual 2020 Annual Meeting of Stockholders

BOSTON, MA / ACCESSWIRE / June 8, 2020 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage... See more »

Pieris Press Releases

May 4, 2020StreetInsider

Pieris Pharmaceuticals to Host First Quarter 2020 Investor Call and Corporate Update on May 11, 2020

BOSTON, MA / ACCESSWIRE / May 4, 2020 / Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage... See more »
March 23, 2020PR-Inside

Pieris Pharmaceuticals Provides Update on Servier Collaboration

(PR-inside.com) BOSTON, MA / ACCESSWIRE / March 23, 2020 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS)... See more »
November 7, 2019Accesswire

Pieris Pharmaceuticals to Host R&D Event

BOSTON, MA / ACCESSWIRE / November 7, 2019 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-s... See more »
November 6, 2019SEC

PIERIS Received $32M in Equity Funding

PIERIS Received $32M in Equity Funding... See more »
November 5, 2019Accesswire

Pieris Pharmaceuticals to Present Phase 1 Data for 4-1BB/HER2 Bispecific PRS-343 at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

BOSTON, MA / ACCESSWIRE / November 5, 2019 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-s... See more »
April 3, 2019PR-Inside

Pieris Pharmaceuticals to Present at the 2019 H.C. Wainwright Global

(PR-inside.com) BOSTON, MA / ACCESSWIRE / April 3, 2019 / Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS)... See more »
March 6, 2019accesswire

Pieris Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference

BOSTON, MA / ACCESSWIRE / March 6, 2019 / Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-sta... See more »

Pieris Videos

Headquarters

255 State Street 9th floor

Boston, Massachusetts02109

1-857-246-8998

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Pieris is a biotechnology company that discovers, develops and commercializes anticalin-based drugs for the treatment of respiratory diseases. Pieris was founded in 2001. Pieris' headquarters is located in Boston, Massachusetts, USA 02109. It has rais...

CEO

Pieris's President & CEO, Stephen S. Yoder, currently has an approval rating of 84%. Pieris's primary competitors are MacroGenics, Molecular Partners & F-star.

Website

pieris.com

Frequently Asked Questions about Pieris

  1. When was Pieris founded?

    Pieris was founded in 2001
  2. Who is Pieris's CEO?

    Pieris's CEO is Stephen S. Yoder
  3. How much revenue does Pieris generate?

    Pieris generates $42.3M in revenue
  4. How much funding does Pieris have?

    Pieris has historically raised $48.5M in funding
  1. Where is Pieris's headquarters?

    Pieris's headquarters is in Boston Massachusetts, USA
  2. How many employees does Pieris have?

    Pieris has 107 employees
  3. What sector does Pieris operate in?

    Pieris is in Pharmaceuticals, Biotechnology
  4. Who are Pieris's competitors?

    Pieris's top competitors are MacroGenics, Molecular Partners, F-star